|
|
Volumn 74, Issue 1, 1995, Pages 167-171
|
|
Molecular basis of fibrinolysis, as relevant for thrombolytic therapy
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ALPHA 2 ANTIPLASMIN;
ANISTREPLASE;
ANTITHROMBOCYTIC AGENT;
FIBRIN;
FIBRINOLYTIC AGENT;
HEPARIN;
PLASMIN;
PLASMINOGEN;
PLASMINOGEN ACTIVATOR;
RECOMBINANT PLASMINOGEN ACTIVATOR;
SEROTONIN ANTAGONIST;
STAPHYLOKINASE;
STREPTOKINASE;
THROMBOXANE SYNTHASE INHIBITOR;
TISSUE PLASMINOGEN ACTIVATOR;
UROKINASE;
ACUTE HEART INFARCTION;
ANTICOAGULATION;
BINDING SITE;
BLEEDING;
BLOOD CLOT LYSIS;
CLINICAL TRIAL;
CONFERENCE PAPER;
CORONARY ARTERY RECANALIZATION;
CORONARY ARTERY THROMBOSIS;
DRUG EFFICACY;
FIBRINOLYSIS;
FIBRINOLYTIC THERAPY;
HUMAN;
IMMUNOGENICITY;
INTRAVENOUS DRUG ADMINISTRATION;
MOLECULAR BIOLOGY;
NONHUMAN;
PATHOGENESIS;
PRIORITY JOURNAL;
PROTEIN DEGRADATION;
PROTEIN PROTEIN INTERACTION;
|
|
EID: 0029144832
PISSN: 03406245
EISSN: None
Source Type: Journal
DOI: 10.1055/s-0038-1642671 Document Type: Conference Paper |
|
Times cited : (95)
|
|
References (0)
|
